BIO-TECHNE Corp Operating Income
BIO-TECHNE Corp (TECH) reported Operating Income of $251.89 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-24
- BIO-TECHNE Corp operating income (loss) for the quarter ending 2026-06-30 was $74.28M.
- BIO-TECHNE Corp operating income (loss) for the quarter ending 2026-03-31 was $75.50M, a 95.04% increase year-over-year.
- BIO-TECHNE Corp operating income (loss) for the quarter ending 2025-12-31 was $54.46M, a 14.85% increase year-over-year.
- BIO-TECHNE Corp operating income (loss) for the quarter ending 2025-09-30 was $47.66M, a 19.18% increase year-over-year.
- BIO-TECHNE Corp operating income (loss) for fiscal 2026 was $251.89M, a 146.34% increase from fiscal 2025.
- BIO-TECHNE Corp operating income (loss) for fiscal 2025 was $102.25M, a 50.53% decline from fiscal 2024.
- BIO-TECHNE Corp operating income (loss) for fiscal 2024 was $206.69M, a 30.86% decline from fiscal 2023.
- BIO-TECHNE Corp operating income (loss) for fiscal 2023 was $298.94M, a 0.79% increase from fiscal 2022.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $74.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $149.77M derived: sum of 2 quarters · filed 2026-08-24 | $204.23M derived: sum of 3 quarters · filed 2026-08-24 | $251.89M 10-K · filed 2026-08-24 | ||||
| 2026-03-31 | $75.50M 10-Q · filed 2026-05-06 | $129.96M derived: sum of 2 quarters · filed 2026-05-06 | $177.61M 10-Q · filed 2026-05-06 | $153.75M derived: sum of 4 quarters · filed 2026-08-24 | ||||
| 2025-12-31 | $54.46M 10-Q · filed 2026-02-04 | $102.12M 10-Q · filed 2026-02-04 | $78.26M derived: sum of 3 quarters · filed 2026-08-24 | $116.97M derived: sum of 4 quarters · filed 2026-08-24 | ||||
| 2025-09-30 | $47.66M 10-Q · filed 2025-11-05 | $23.80M derived: sum of 2 quarters · filed 2026-08-24 | $62.51M derived: sum of 3 quarters · filed 2026-08-24 | $109.92M derived: sum of 4 quarters · filed 2026-08-24 | ||||
| 2025-06-30 | -$23.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $14.85M derived: sum of 2 quarters · filed 2026-08-24 | $62.27M derived: sum of 3 quarters · filed 2026-08-24 | $102.25M 10-K · filed 2026-08-24 | ||||
| 2025-03-31 | $38.71M 10-Q · filed 2026-05-06 | $86.13M derived: sum of 2 quarters · filed 2026-05-06 | $126.11M 10-Q · filed 2026-05-06 | $171.94M derived: sum of 4 quarters · filed 2026-08-24 | ||||
| 2024-12-31 | $47.42M 10-Q · filed 2026-02-04 | $87.41M 10-Q · filed 2026-02-04 | $133.23M derived: sum of 3 quarters · filed 2026-08-24 | $200.23M derived: sum of 4 quarters · filed 2026-08-24 | ||||
| 2024-09-30 | $39.99M 10-Q · filed 2025-11-05 | $85.81M derived: sum of 2 quarters · filed 2026-08-24 | $152.81M derived: sum of 3 quarters · filed 2026-08-24 | $190.81M derived: sum of 4 quarters · filed 2026-08-24 | ||||
| 2024-06-30 | $45.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $112.82M derived: sum of 2 quarters · filed 2026-08-24 | $150.82M derived: sum of 3 quarters · filed 2026-08-24 | $206.69M 10-K · filed 2026-08-24 | ||||
| 2024-03-31 | $67.00M 10-Q · filed 2025-05-08 | $105.00M derived: sum of 2 quarters · filed 2025-05-08 | $160.86M 10-Q · filed 2025-05-08 | $255.39M derived: sum of 4 quarters · filed 2025-08-22 | ||||
| 2023-12-31 | $38.00M 10-Q · filed 2025-02-06 | $93.87M 10-Q · filed 2025-02-06 | $188.39M derived: sum of 3 quarters · filed 2025-08-22 | $268.60M derived: sum of 4 quarters · filed 2025-08-22 | ||||
| 2023-09-30 | $55.86M 10-Q · filed 2024-11-05 | $150.39M derived: sum of 2 quarters · filed 2025-08-22 | $230.60M derived: sum of 3 quarters · filed 2025-08-22 | $298.49M derived: sum of 4 quarters · filed 2025-08-22 | ||||
| 2023-06-30 | $94.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $174.74M derived: sum of 2 quarters · filed 2025-08-22 | $242.63M derived: sum of 3 quarters · filed 2025-08-22 | $298.94M 10-K · filed 2025-08-22 | ||||
| 2023-03-31 | $80.21M 10-Q · filed 2024-05-06 | $148.10M derived: sum of 2 quarters · filed 2024-05-06 | $204.42M 10-Q · filed 2024-05-06 | $284.99M derived: sum of 4 quarters · filed 2024-08-22 | ||||
| 2022-12-31 | $67.89M 10-Q · filed 2024-02-07 | $124.21M 10-Q · filed 2024-02-07 | $204.78M derived: sum of 3 quarters · filed 2024-08-22 | $295.23M derived: sum of 4 quarters · filed 2024-08-22 | ||||
| 2022-09-30 | $56.32M 10-Q · filed 2023-11-07 | $136.89M derived: sum of 2 quarters · filed 2024-08-22 | $227.34M derived: sum of 3 quarters · filed 2024-08-22 | $289.69M derived: sum of 4 quarters · filed 2024-08-22 | ||||
| 2022-06-30 | $80.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | $171.02M derived: sum of 2 quarters · filed 2024-08-22 | $233.37M derived: sum of 3 quarters · filed 2024-08-22 | $296.59M 10-K · filed 2024-08-22 | ||||
| 2022-03-31 | $90.45M 10-Q · filed 2023-05-08 | $152.79M derived: sum of 2 quarters · filed 2023-05-08 | $216.02M 10-Q · filed 2023-05-08 | $284.60M derived: sum of 4 quarters · filed 2023-08-23 | ||||
| 2021-12-31 | $62.35M 10-Q · filed 2023-02-07 | $125.57M 10-Q · filed 2023-02-07 | $194.15M derived: sum of 3 quarters · filed 2023-08-23 | $262.78M derived: sum of 4 quarters · filed 2023-08-23 | ||||
| 2021-09-30 | $63.22M 10-Q · filed 2022-11-07 | $131.80M derived: sum of 2 quarters · filed 2023-08-23 | $200.43M derived: sum of 3 quarters · filed 2023-08-23 | $251.43M derived: sum of 4 quarters · filed 2023-08-23 | ||||
| 2021-06-30 | $68.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $137.21M derived: sum of 2 quarters · filed 2023-08-23 | $188.20M derived: sum of 3 quarters · filed 2023-08-23 | $237.30M 10-K · filed 2023-08-23 | ||||
| 2021-03-31 | $68.63M 10-Q · filed 2022-05-09 | $119.62M derived: sum of 2 quarters · filed 2022-05-09 | $168.71M 10-Q · filed 2022-05-09 | $208.02M derived: sum of 4 quarters · filed 2022-08-24 | ||||
| 2020-12-31 | $50.99M 10-Q · filed 2022-02-07 | $100.09M 10-Q · filed 2022-02-07 | $139.40M derived: sum of 3 quarters · filed 2022-08-24 | $187.19M derived: sum of 4 quarters · filed 2022-08-24 | ||||
| 2020-09-30 | $49.09M 10-Q · filed 2021-11-08 | $88.40M derived: sum of 2 quarters · filed 2022-08-24 | $136.19M derived: sum of 3 quarters · filed 2022-08-24 | $173.19M derived: sum of 4 quarters · filed 2022-08-24 | ||||
| 2020-06-30 | $39.31M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24 | $87.10M derived: sum of 2 quarters · filed 2022-08-24 | $124.09M derived: sum of 3 quarters · filed 2022-08-24 | $157.42M 10-K · filed 2022-08-24 | ||||
| 2020-03-31 | $47.79M 10-Q · filed 2021-05-07 | $84.78M derived: sum of 2 quarters · filed 2021-05-07 | $118.11M 10-Q · filed 2021-05-07 | $161.37M derived: sum of 4 quarters · filed 2021-08-25 | ||||
| 2019-12-31 | $36.99M 10-Q · filed 2021-02-08 | $70.32M 10-Q · filed 2021-02-08 | $113.58M derived: sum of 3 quarters · filed 2021-08-25 | $157.67M derived: sum of 4 quarters · filed 2021-08-25 | ||||
| 2019-09-30 | $33.33M 10-Q · filed 2020-11-09 | $76.59M derived: sum of 2 quarters · filed 2021-08-25 | $120.68M derived: sum of 3 quarters · filed 2021-08-25 | $154.28M derived: sum of 4 quarters · filed 2021-08-25 | ||||
| 2019-06-30 | $43.26M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | $87.35M derived: sum of 2 quarters · filed 2021-08-25 | $120.96M derived: sum of 3 quarters · filed 2021-08-25 | $146.72M 10-K · filed 2021-08-25 | ||||
| 2019-03-31 | $44.09M 10-Q · filed 2020-05-11 | $77.69M derived: sum of 2 quarters · filed 2020-05-11 | $103.45M 10-Q · filed 2020-05-11 | $146.37M derived: sum of 4 quarters · filed 2020-08-26 | ||||
| 2018-12-31 | $33.60M 10-Q · filed 2020-02-06 | $59.36M 10-Q · filed 2020-02-06 | $102.28M derived: sum of 3 quarters · filed 2020-08-26 | $145.37M derived: sum of 4 quarters · filed 2020-08-26 | ||||
| 2018-09-30 | $25.76M 10-Q · filed 2019-11-06 | $68.68M derived: sum of 2 quarters · filed 2020-08-26 | $111.76M derived: sum of 3 quarters · filed 2020-08-26 | $135.91M derived: sum of 4 quarters · filed 2020-08-26 | ||||
| 2018-06-30 | $42.91M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26 | $86.00M derived: sum of 2 quarters · filed 2020-08-26 | $110.15M derived: sum of 3 quarters · filed 2020-08-26 | $136.18M 10-K · filed 2020-08-26 | ||||
| 2018-03-31 | $43.08M 10-Q · filed 2019-05-07 | $67.23M derived: sum of 2 quarters · filed 2019-05-07 | $93.26M 10-Q · filed 2019-05-07 | $133.31M derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2017-12-31 | $24.15M 10-Q · filed 2019-02-07 | $50.18M 10-Q · filed 2019-02-07 | $90.22M derived: sum of 3 quarters · filed 2019-11-06 | $123.73M derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2017-09-30 | $26.03M 10-Q · filed 2018-11-07 | $66.08M derived: sum of 2 quarters · filed 2019-11-06 | $99.58M derived: sum of 3 quarters · filed 2019-11-06 | $117.46M derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2017-06-30 | $40.05M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | $73.55M derived: sum of 2 quarters · filed 2019-11-06 | $91.43M derived: sum of 3 quarters · filed 2019-11-06 | $120.58M 10-K/A · filed 2019-11-06 | ||||
| 2017-03-31 | $33.50M 10-Q · filed 2018-05-09 | $32.30M 10-Q · filed 2017-05-10 | $51.38M derived: sum of 2 quarters · filed 2018-05-09 | $80.54M 10-Q · filed 2018-05-09 | $73.89M 10-Q · filed 2017-05-10 | $120.55M derived: sum of 4 quarters · filed 2018-08-27 | ||
| 2016-12-31 | $17.88M 10-Q · filed 2018-02-08 | $16.15M 10-Q · filed 2017-02-09 | $47.04M 10-Q · filed 2018-02-08 | $41.59M 10-Q · filed 2017-02-09 | $87.05M derived: sum of 3 quarters · filed 2018-08-27 | $130.58M derived: sum of 4 quarters · filed 2018-08-27 | ||
| 2016-09-30 | $29.16M 10-Q · filed 2017-11-09 | $25.44M 10-Q · filed 2016-11-09 | $69.17M derived: sum of 2 quarters · filed 2018-08-27 | $112.69M derived: sum of 3 quarters · filed 2018-08-27 | $148.72M derived: sum of 4 quarters · filed 2018-08-27 | |||
| 2016-06-30 | $40.01M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-27 | $83.54M derived: sum of 2 quarters · filed 2018-08-27 | $119.56M derived: sum of 3 quarters · filed 2018-08-27 | $150.59M 10-K · filed 2018-08-27 | ||||
| 2016-03-31 | $43.53M 10-Q · filed 2017-05-10 | $79.55M derived: sum of 2 quarters · filed 2017-05-10 | $110.58M 10-Q · filed 2017-05-10 | $148.38M derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-12-31 | $36.02M 10-Q · filed 2017-02-09 | $67.05M 10-Q · filed 2017-02-09 | $104.85M derived: sum of 3 quarters · filed 2017-09-07 | $144.28M derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-09-30 | $31.03M 10-Q · filed 2016-11-09 | $68.83M derived: sum of 2 quarters · filed 2017-09-07 | $108.25M derived: sum of 3 quarters · filed 2017-09-07 | $142.84M derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-06-30 | $37.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $77.23M derived: sum of 2 quarters · filed 2017-09-07 | $111.81M derived: sum of 3 quarters · filed 2017-09-07 | $147.02M 10-K · filed 2017-09-07 | $147.02K 10-K · filed 2015-08-31 | |||
| 2015-03-31 | $39.43M 10-Q · filed 2016-05-10 | $74.01M derived: sum of 2 quarters · filed 2016-05-10 | $109.22M 10-Q · filed 2016-05-10 | $148.07M derived: sum of 4 quarters · filed 2016-08-29 | ||||
| 2014-12-31 | $34.58M 10-Q · filed 2016-02-09 | $69.80M 10-Q · filed 2016-02-09 | $108.64M derived: sum of 3 quarters · filed 2016-08-29 | $154.41M derived: sum of 4 quarters · filed 2016-08-29 | ||||
| 2014-09-30 | $35.22M 10-Q · filed 2015-11-09 | $74.06M derived: sum of 2 quarters · filed 2016-08-29 | $119.83M derived: sum of 3 quarters · filed 2016-08-29 | $155.57M derived: sum of 4 quarters · filed 2016-08-29 | ||||
| 2014-06-30 | $38.85M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | $84.61M derived: sum of 2 quarters · filed 2016-08-29 | $120.36M derived: sum of 3 quarters · filed 2016-08-29 | $159.75M 10-K · filed 2016-08-29 | ||||
| 2014-03-31 | $45.77M 10-Q · filed 2015-05-11 | $81.51M derived: sum of 2 quarters · filed 2015-05-11 | $120.90M 10-Q · filed 2015-05-11 | $2.41M derived: sum of 4 quarters · filed 2015-08-31 | ||||
| 2013-12-31 | $35.74M 10-Q · filed 2015-02-09 | $75.14M 10-Q · filed 2015-02-09 | -$43.36M derived: sum of 3 quarters · filed 2015-08-31 | $586.47K derived: sum of 4 quarters · filed 2015-08-31 | ||||
| 2013-09-30 | $39.39M 10-Q · filed 2014-11-10 | -$79.10M derived: sum of 2 quarters · filed 2015-08-31 | -$35.16M derived: sum of 3 quarters · filed 2015-08-31 | $1.75M derived: sum of 4 quarters · filed 2015-08-31 | ||||
| 2013-06-30 | -$118.49M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31 | -$74.55M derived: sum of 2 quarters · filed 2015-08-31 | -$37.64M derived: sum of 3 quarters · filed 2015-08-31 | $158.47K 10-K · filed 2015-08-31 | $158.47M 10-K · filed 2013-08-29 | |||
| 2013-03-31 | $43.95M 10-Q · filed 2014-05-12 | $80.85M derived: sum of 2 quarters · filed 2014-05-12 | $118.65M 10-Q · filed 2014-05-12 | $159.87M derived: sum of 4 quarters · filed 2014-08-29 | ||||
| 2012-12-31 | $36.90M 10-Q · filed 2014-02-04 | $74.71M 10-Q · filed 2014-02-04 | $115.92M derived: sum of 3 quarters · filed 2014-08-29 | $162.29M derived: sum of 4 quarters · filed 2014-08-29 | ||||
| 2012-09-30 | $37.80M 10-Q · filed 2013-11-12 | $79.02M derived: sum of 2 quarters · filed 2014-08-29 | $125.38M derived: sum of 3 quarters · filed 2014-08-29 | $163.06M derived: sum of 4 quarters · filed 2014-08-29 | ||||
| 2012-06-30 | $41.22M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-29 | $87.58M derived: sum of 2 quarters · filed 2014-08-29 | $125.26M derived: sum of 3 quarters · filed 2014-08-29 | $166.21M 10-K · filed 2014-08-29 | ||||
| 2012-03-31 | $46.36M 10-Q · filed 2013-05-10 | $84.04M derived: sum of 2 quarters · filed 2013-05-10 | $124.99M 10-Q · filed 2013-05-10 | $167.59M derived: sum of 4 quarters · filed 2013-08-29 | ||||
| 2011-12-31 | $37.68M 10-Q · filed 2013-02-11 | $78.63M 10-Q · filed 2013-02-11 | $121.23M derived: sum of 3 quarters · filed 2013-08-29 | $165.97M derived: sum of 4 quarters · filed 2013-08-29 | ||||
| 2011-09-30 | $40.95M 10-Q · filed 2012-11-09 | $83.55M derived: sum of 2 quarters · filed 2013-08-29 | $128.29M derived: sum of 3 quarters · filed 2013-08-29 | $165.64M derived: sum of 4 quarters · filed 2013-08-29 | ||||
| 2011-06-30 | $42.60M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | $87.34M derived: sum of 2 quarters · filed 2013-08-29 | $124.69M derived: sum of 3 quarters · filed 2013-08-29 | $163.06M 10-K · filed 2013-08-29 | ||||
| 2011-03-31 | $44.74M 10-Q · filed 2012-05-10 | $82.09M derived: sum of 2 quarters · filed 2012-05-10 | $120.45M 10-Q · filed 2012-05-10 | $159.38M derived: sum of 4 quarters · filed 2012-08-29 | ||||
| 2010-12-31 | $37.35M 10-Q · filed 2012-02-07 | $75.71M 10-Q · filed 2012-02-07 | $114.64M derived: sum of 3 quarters · filed 2012-08-29 | $156.29M derived: sum of 4 quarters · filed 2012-08-29 | ||||
| 2010-09-30 | $38.36M 10-Q · filed 2011-11-09 | $77.29M derived: sum of 2 quarters · filed 2012-08-29 | $118.94M derived: sum of 3 quarters · filed 2012-08-29 | $155.49M derived: sum of 4 quarters · filed 2012-08-29 | ||||
| 2010-06-30 | $38.92M derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-29 | $80.57M derived: sum of 2 quarters · filed 2012-08-29 | $117.13M derived: sum of 3 quarters · filed 2012-08-29 | $156.33M 10-K · filed 2012-08-29 | ||||
| 2010-03-31 | $41.65M 10-Q · filed 2011-05-10 | $78.20M derived: sum of 2 quarters · filed 2011-05-10 | $117.40M 10-Q · filed 2011-05-10 | |||||
| 2009-12-31 | $36.55M 10-Q · filed 2011-02-09 | $75.75M 10-Q · filed 2011-02-09 | ||||||
| 2009-09-30 | $39.20M 10-Q · filed 2010-11-09 | |||||||
| 2009-06-30 | $150.78M 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |